Back

Chronic liver disease as a predictor of one-year outcomes after cardiac resynchronization therapy implantation

22 May 2022 (08:30 - 19:45)
Organised by:
Congress Presentation Part of: Heart Failure ePosters - focus on Chronic Heart Failure 6 Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2022

About the speaker

Photo
Doctor Joana Correia

Hospital Sao Teotonio, Viseu (Portugal)

34 More presentations in this session

Presentation thumbnail
Prospective evaluation of left heart echocardiographic parameters of the EMPAG-HF patient cohort(effects of empagliflozin on diuresis and renal function in patients with acute decompensated HF)
Mr J. Bogoviku (Jena, DE)
Abstract Slides
Presentation thumbnail
Pharmacological inhibition of Hippo pathway with XMU-MP-1 does not improve outcomes in mice with autoimmune myocarditis.
Doctor M. Nieto (Valladolid, ES)
Abstract Slides
Presentation thumbnail
T cell and antibody response following double dose of BNT162b2 mRNA Vaccine in heart transplant recipients
Doctor M. Vanderheyden (Aalst, BE)
Abstract Slides
Presentation thumbnail
Device-detected sleep-disordered breathing predicts implantable defibrillator therapy in patients with heart failure.
Doctor A. Mazza (Orvieto, IT)
Abstract Slides
Presentation thumbnail
A preliminary evaluation of a novel lifestyle intervention in patients with hypertrophic cardiomyopathy
Miss A. Fuller (Newcastle-Upon-Tyne, GB)
Abstract Slides

Access the full session

Session thumbnail
Heart Failure ePosters - focus on Chronic Heart Failure 6

The Event

Event poster

Heart Failure 2022

22 May 2022 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources